Sagimet Biosciences Inc. Series A
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMT and other ETFs, options, and stocks.About SGMT
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
SGMT Key Statistics
Stock Snapshot
As of today, Sagimet Biosciences Inc. Series A(SGMT) shares are valued at $5.45. The company's market cap stands at 177.57M, with a P/E ratio of -3.22.
On 2026-03-05, Sagimet Biosciences Inc. Series A(SGMT) stock moved within a range of $5.38 to $5.74. With shares now at $5.45, the stock is trading +1.4% above its intraday low and -5.1% below the session's peak.
Trading activity shows a volume of 379.96K, compared to an average daily volume of 405.15K.
Over the past 52 weeks, Sagimet Biosciences Inc. Series A(SGMT) stock has traded between a high of $11.41 and a low of $1.73.
Over the past 52 weeks, Sagimet Biosciences Inc. Series A(SGMT) stock has traded between a high of $11.41 and a low of $1.73.
Analyst ratings
91%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.